ConductScience.org, home

Trial · NCT07902349

Endotracheal Tube Versus Transcartilage Needle Electrodes for Nerve Monitoring in Thyroid Surgery

NCT07902349, Not applicable, Not yet recruiting, Marmara University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Endotracheal Tube Versus Transcartilage Needle Electrodes for Nerve Monitoring in Thyroid Surgery. Trials, record NCT07902349. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902349

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Endotracheal Tube Versus Transcartilage Needle Electrodes for Nerve Monitoring in Thyroid Surgery
NCT number
NCT07902349
Status
Not yet recruiting
Phases
Not applicable
Enrollment
100 participants, estimated
Lead sponsor
Marmara University
Conditions
Thyroid Diseases, Recurrent Laryngeal Nerve Injury, Vocal Cord Paralysis, Thyroid Nodule
Interventions
Transcartilage needle electrode recording, Endotracheal tube surface electrode recording
First posted
2026-10-28
Last updated
2026-10-30

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryRate of false amplitude decrease greater than 50%Intraoperative recording (up to 4 hours), with true nerve injury status ascertained by postoperative laryngoscopy within 2 weeks after surgery
Proportion of evaluations in which the amplitude at vagal stimulation after resection (V2) is more than 50% lower than the amplitude at vagal stimulation before resection (V1), among nerves in which no true nerve injury is present. One nerve per patient is analyzed, on the first side evaluated, and the two electrode types are compared within the same nerve using the two-sided exact McNemar test. True nerve injury is determined by a combination of a standard loss-of-signal algorithm, intraoperative findings and, where indicated, postoperative laryngoscopy performed within 2 weeks after surgery.
SecondaryProportion of evaluations with a baseline amplitude of 500 microvolts or more at vagal stimulation before resection (V1)Intraoperative, before resection (up to 2 hours)
SecondaryProportion of evaluations in which the final amplitude is unchanged or higher than baselineIntraoperative, up to 4 hours
SecondarySignal amplitude in microvolts at each stimulation stepIntraoperative, up to 4 hours
Amplitude recorded at vagal stimulation before dissection (V1), recurrent laryngeal nerve stimulation after identification (R1), recurrent laryngeal nerve stimulation after completion of lobar dissection (R2) and vagal stimulation at the end of the procedure (V2).
SecondarySignal latency in milliseconds at each stimulation stepIntraoperative, up to 4 hours
Latency recorded at vagal stimulation before dissection (V1), recurrent laryngeal nerve stimulation after identification (R1), recurrent laryngeal nerve stimulation after completion of lobar dissection (R2) and vagal stimulation at the end of the procedure (V2).
SecondaryRate of technical failure, defined as failure to obtain a baseline signalIntraoperative, before resection (up to 2 hours)
SecondaryPositive and negative predictive value of each electrode type for true nerve injuryFrom surgery to 3 months after surgery
SecondaryChange in Turkish Voice Handicap Index-10 total scoreBaseline, 2 weeks and 3 months after surgery
The Turkish version of the Voice Handicap Index-10 (VHI-10) is a 10-item patient-reported questionnaire on voice-related handicap. Each item is scored from 0 to 4, giving a total score from 0 (best) to 40 (worst). Higher scores indicate greater voice handicap, so an increase from baseline is a worse outcome.
SecondaryChange in Turkish Eating Assessment Tool-10 total scoreBaseline, 2 weeks and 3 months after surgery
The Turkish version of the Eating Assessment Tool-10 (EAT-10) is a 10-item patient-reported questionnaire on swallowing difficulty. Each item is scored from 0 to 4, giving a total score from 0 (best) to 40 (worst). Higher scores indicate greater swallowing difficulty, so an increase from baseline is a worse outcome.
SecondaryIncidence of adverse events attributed to electrode placementFrom surgery to 3 months after surgery

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07902349

GET https://conductscience.org/api/trials/v1/NCT07902349/registered